E. А. Belousova

2.2k total citations
36 papers, 328 citations indexed

About

E. А. Belousova is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, E. А. Belousova has authored 36 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 21 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in E. А. Belousova's work include Inflammatory Bowel Disease (20 papers), Microscopic Colitis (16 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). E. А. Belousova is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Microscopic Colitis (16 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). E. А. Belousova collaborates with scholars based in Russia, United States and Ireland. E. А. Belousova's co-authors include Milan Lukáš, Bruce Yacyshyn, William J. Sandborn, Brian G. Feagan, Piotr Krzeski, Jarosław Reguła, Stephen B. Hanauer, Seema Mihrshahi, Guy B. Marks and Jennifer Peat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of the Rheumatic Diseases.

In The Last Decade

E. А. Belousova

24 papers receiving 315 citations

Peers

E. А. Belousova
Yoon‐Kyo An Australia
Khadija Chaudrey United States
Aurelio Lorenzo Spain
Eran Matz Israel
Damian Dowling Australia
Hang Hock Shim Singapore
Farhad Peerani Canada
Eric J. Mao United States
Ross Knight Australia
V Chhaya United Kingdom
Yoon‐Kyo An Australia
E. А. Belousova
Citations per year, relative to E. А. Belousova E. А. Belousova (= 1×) peers Yoon‐Kyo An

Countries citing papers authored by E. А. Belousova

Since Specialization
Citations

This map shows the geographic impact of E. А. Belousova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. А. Belousova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. А. Belousova more than expected).

Fields of papers citing papers by E. А. Belousova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. А. Belousova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. А. Belousova. The network helps show where E. А. Belousova may publish in the future.

Co-authorship network of co-authors of E. А. Belousova

This figure shows the co-authorship network connecting the top 25 collaborators of E. А. Belousova. A scholar is included among the top collaborators of E. А. Belousova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. А. Belousova. E. А. Belousova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belousova, E. А., et al.. (2024). Treatment of mildandmoderateforms of ulcerativecolitis: the possibilities of mesalazine. Meditsinskiy sovet = Medical Council. 182–189. 1 indexed citations
2.
Belousova, E. А., et al.. (2024). The role of clarifying endoscopic techniques in determining the degree of activity in patients with inflammatory bowel diseases. Experimental and Clinical Gastroenterology. 43–50.
3.
Belousova, E. А., et al.. (2024). The post-COVID-19 intestinal damages: clinical, endoscopic and morphological features. The results of a single-center prospective observational cohort study. SHILAP Revista de lepidopterología. 51(8). 427–440. 1 indexed citations
4.
5.
Belousova, E. А., et al.. (2023). Endosonographic changes of the pancreas in patients with inflammatory bowel diseases and chronic pancreatitis. Experimental and Clinical Gastroenterology. 53–60.
6.
Belousova, E. А., et al.. (2023). Differential diagnosis of inflammatory bowel diseases by endoscopic ultrasound. SHILAP Revista de lepidopterología. 50(6). 400–407.
7.
8.
Veselov, А. V., et al.. (2020). ECONOMIC BURDEN AND CURRENT STATUS OF THE DRUG SUPPLY MANAGEMENT FOR IMMUNE INFLAMMATORY DISEASES (BY EXAMPLE OF ULCERATIVE COLITIS AND CROHN’S DISEASE). Problems of Social Hygiene Public Health and History of Medicine. 28(Special Issue). 1137–1145. 6 indexed citations
9.
Belousova, E. А., et al.. (2020). Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis). SHILAP Revista de lepidopterología. 121–126.
10.
Belousova, E. А., Aleksei Zulkarnaev, Д. Е. Каратеев, et al.. (2020). Particulars of the comprehensive treatment of the patients with the new coronavirus infection (COVID-19): guidelines on the in-patient management. SHILAP Revista de lepidopterología. 48. 91–142. 3 indexed citations
11.
Belousova, E. А., И. Г. Бакулин, А. V. Veselov, et al.. (2019). EXPERIENCE OF TOFACITINIB USING IN THERAPY OF ULCERATIVE COLITIS IN REAL CLINICAL PRACTICE. Koloproktologia. 18(4). 86–99. 9 indexed citations
12.
13.
Дмитриева, Н. В., G. A. Klyasova, Н. В. Бакулина, et al.. (2018). Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study). Infectious Diseases and Therapy. 7(4). 523–534. 3 indexed citations
14.
15.
Belousova, E. А. & И. Л. Халиф. (2012). Tu1290 Social, Demographic and Clinical Features of Inflammatory Bowel Disease in Russia. Gastroenterology. 142(5). S–794. 3 indexed citations
16.
Groß, Volker, Ivan Bunganič, E. А. Belousova, et al.. (2010). 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 5(2). 129–138. 51 indexed citations
17.
Sandborn, William J., Jarosław Reguła, Brian G. Feagan, et al.. (2009). Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis. Gastroenterology. 137(6). 1934–1943.e3. 119 indexed citations
18.
Бакулин, И. Г., et al.. (2008). [Activity indices--objective criteria of the estimation of severity level of ulcerous colitis].. PubMed. 14–6.
19.
Mihrshahi, Seema, E. А. Belousova, Guy B. Marks, & Jennifer Peat. (2003). Pregnancy and Birth Outcomes in Families with Asthma. Journal of Asthma. 40(2). 181–187. 38 indexed citations
20.
Belousova, E. А., et al.. (1990). Cyclic Nucleotide Concentrations of Rectal Mucosa in Ulcerative Colitis. Scandinavian Journal of Gastroenterology. 25(4). 341–344. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoon‐Kyo An Breakdown of academic impact, for papers by Khadija Chaudrey Breakdown of academic impact, for papers by Aurelio Lorenzo Breakdown of academic impact, for papers by Eran Matz Breakdown of academic impact, for papers by Damian Dowling Breakdown of academic impact, for papers by Hang Hock Shim Breakdown of academic impact, for papers by Farhad Peerani Breakdown of academic impact, for papers by Eric J. Mao Breakdown of academic impact, for papers by Ross Knight Breakdown of academic impact, for papers by V Chhaya
Rankless by CCL
2026